Last reviewed · How we verify
NCT04183556
The Effect of Turmeric on New Onset Primary Dysmenorrhea
NA trial testing Naproxen in Primary Dysmenorrhea in 90 participants. Completed in 23 April 2020.
23 April 2020
Quick facts
| Lead sponsor | Batman Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 15 November 2019 |
| Primary completion | 23 April 2020 |
| Estimated completion | 23 April 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
Conditions studied
- Primary Dysmenorrhea — all drugs for Primary Dysmenorrhea →
Sponsor
Batman Training and Research Hospital
Who can join
Adults 16 to 35, female only, with Primary Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study was planned as 150 patients. Patients who met early-onset dysmenorrhea criteria and who met the inclusion criteria; 150 patients were divided into 2 equal groups, and NSAID during the menstrual cycle, nsai + turmeric 1 gr oral powder form treatment was planned to be started in the other group. The pain frequency and severity before and after treatment were evaluated by visual analog scale and the two groups were compared.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04183556
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Naproxen
Trials testing the same drug.
- NCT07277712 — A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers · Phase 1 · not yet recruiting
- NCT05411718 — A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syn · Phase 2 · recruiting
- NCT07204379 — Effect of Oral Analgesics on Post-op Pain · EARLY_PHASE1 · completed
- NCT06948513 — Effect of Over-the-counter Analgesics on Postoperative Pain · Phase 3 · completed
- NCT05237297 — Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole · Phase 1 · completed
Other recruiting trials for Primary Dysmenorrhea
Currently open trials in the same condition.
- NCT07409337 — Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms · NA · recruiting
- NCT06995287 — Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysme · Phase 3 · recruiting
- NCT07352982 — Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea · NA · recruiting
- NCT07239232 — "Knee Joint Position Sense and Dynamic Balance in Females With Primary Dysmenorrhea · recruiting
- NCT07314021 — Primary Dysmenorrhea and Mobilization. · NA · active not recruiting
Other Batman Training and Research Hospital trials
Trials by the same sponsor.
- NCT05988151 — New Surgical Approach in Labioplasty · completed
- NCT05920655 — Comparison of Ocular Changes by Surgical Menopause Using Optical Coherence Tomography (OCT) · completed
- NCT04703231 — Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause · completed
- NCT04528186 — The Effect of Healthy Eating Index on Maternal Thyroid Volume in Hyperemesis Gravidarum · completed
- NCT05927740 — The Efficacy of Hyperemesis Gravidarum on Macular Thickness, Corneal Thickness and Intraocular Pressure in Pregnancy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04183556 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Batman Training and Research Hospital
- Last refreshed: 24 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04183556.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing